US Diabetic Macular Edema (DME) by Therapy Type (Anti-VEGF, corticosteroids, and other off-label drugs) by Route of Administration (Intravitreal Injections & Intravitreal Implants) By Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Others) Growth, Trends and Forecast, 2019-2028
- Published Date: 2022-12-26
- Report ID: 138124
- Pages: 200
-
Format:
Report Overview
The US Diabetic Macular Edema (DME) market size stood at around USD $2.0 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during
Diabetic Macular Edema (DME) is the accumulation of fluid in the macula part of the retina due to leaking blood vessels. DME is a major complication of diabetes and a leading cause of vision loss in persons with diabetes mellitus. In 2018, 2.4 m people in the US had Diabetic Macular Edema (DME), of that only 70% got diagnosed and treated. US alone is contributing to 51% market share, owing to the higher incidence rates of diabetes amongst the other developed nations
Market Drivers
Increasing the prevalence of diabetes is the prime factor driving the growth of the Diabetic Macular Edema market. Besides, the substantial Research and Development investment by pharmaceutical companies and the launch of several promising emerging therapies will fuel market growth
1. US Diabetic Macular Edema Market Overview
A. Market Size
2. US Diabetic Macular Edema Market Growth Drivers
A. Increasing prevalence of diabetic market
B. R&D investment by pharmaceutical companies
3. US Diabetic Macular Edema Market Segmentation
A. By Therapy type
I. Anti-VEGF
II. Corticosteroids
III. Other Off-label Drugs
B. By Route of Administration
I. Intravitreal Injections
II. Intravitreal Implants
C. By Distribution Channel
I. Hospitals Pharmacies
II. Retail Pharmacies
III. Others
4. US Diabetic Macular Edema Major Market Share
A. Market Analysis, Insights and Forecast by Revenue
5. Competitive Landscape
A. Major Players
B. Products in Pipeline
6. Key Company Profiles
A. Roche Company overview, Product & Services, Strategies & Financials
B. Genentech Company overview, Product & Services, Strategies & Financials
C. BMS Company overview, Product & Services, Strategies & Financials
7. Healthcare Policies and Regulatory Landscape.
A. Policy Changes and Reimbursement Scenario
8. Factors Driving Market Growth
A. Key Industry Developments
B. Mergers and Acquisitions
9. Market Opportunities and Future Trends
A. Market Opportunities
B. Future Trends
10. Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
